Device Authority targets a more practical route into automotive cybersecurity spending

Tern plc

Device Authority is trying to make its Industry Proof of Value relevant at a point when automotive cybersecurity is becoming a more immediate operational issue for manufacturers and suppliers. The company’s argument is straightforward. PKI and key management are no longer just technical matters. As vehicle architectures become more software-defined and connected, and as regulatory requirements tighten, control over cryptographic processes is moving closer to the centre of how OEMs manage risk, compliance and production.

Device Authority is offering a defined way for OEMs and Tier 1 suppliers to test how secure device identity, certificate lifecycle management, key generation, storage, distribution and BYOK models would work in practice. The point of the PoV is to move discussions away from theory and into a measurable operating model without requiring a full deployment at the outset.

This makes the proposition easier to understand commercially. In markets where decision cycles are long and implementation risk is closely scrutinised, a structured proof environment can help customers test both technical fit and regulatory relevance before making a wider commitment. That is important because buyers in this area are not simply looking for another cybersecurity product. They are trying to establish whether they can show control, retain visibility and support production at scale under tighter compliance expectations.

Device Authority is also placing clear emphasis on regulatory alignment. The source says the PoV is designed to map technical outcomes to requirements such as cryptographic governance, certificate traceability, secure lifecycle controls, production auditability and rapid revocation and update capabilities.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search